ArticleClinical case reports2026
Peripartum Management of Vagus Nerve Stimulation and Antiseizure Medications During Two Pregnancies in a Woman With Drug-Resistant Epilepsy: A Case Report.
Article in Clinical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
There are limited reports on vagus nerve stimulation (VNS) therapy during pregnancy. We report a case of two pregnancies in a woman with drug-resistant epilepsy (DRE) managed with VNS. A woman with epilepsy underwent implantation of a VNS device because antiseizure medications (ASMs) and a lobectomy were not sufficient to control seizures. After a spontaneous pregnancy at 29 years old, she could continue epilepsy treatment as before pregnancy by only adjusting the VNS settings. A vaginal delivery was planned, but an emergency cesarean section was performed at 38 weeks' gestation due to chorioamnionitis, complicated by neonatal asphyxia and transient tachypnea of the newborn; both mother and infant recovered fully. Two years later, she conceived her second child spontaneously and continued ASM and VNS treatment as before, delivering by scheduled cesarean section at 37 weeks' gestation; the infant required treatment for transient tachypnea of the newborn but recovered well. This case illustrates that stable seizure control without ASM escalation is achievable during pregnancy in a patient with VNS-treated DRE whose seizures were well controlled before conception. However, the relative contribution of VNS itself cannot be determined from this experience.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.